Tumor necrosis factor-␣ (TNF-␣) plays a crucial role in the early defense against pathogens. This cytokine is produced by several cell types including T lymphocytes expressing the ␣ as well as the ␥␦ T cell receptor (TcR). In human, the circulating ␥␦ T cells, which mostly express V␥9V␦2 TcR, have been strongly suggested to play an important protective role against infectious agents. These activated cells early produce high amounts of TNF-␣, which induce a determinant beneficial effect against development of intracellular pathogens; however, sustained production of this cytokine can result in immunopathological diseases. The signals that regulate TNF-␣ production in V␥9V␦2 T cells are totally unknown. In primary ␣ T cells, TNF-␣ production was shown to necessitate engagement of the TcR and CD28, and to be independent of the p38 mitogen activated protein kinase pathway. We demonstrate herein that, in contrast to ␣ T cells, TNF-␣ production in V␥9V␦2 T lymphocytes is independent of CD28 costimulation and highly dependent on TcR-induced p38 kinase and extracellular signal-regulated kinase 2 pathway activation for optimal cytokine release. Moreover, we bring elements supporting the idea that the "activation threshold" of ␥␦ T cells leading to cytokine production is lower than that of ␣ T cells.